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background: Biomarker studies in chronic heart failure (HF) have traditionally focused on the outcome measures of mortality or first 
hospitalization without the inclusion of hospitalization as a possibly recurrent event. We sought to determine the utility of circulating markers to 
identify patients at high risk for cardiac hospitalization in a recurrent event framework.
Methods: We measured a panel of 9 biomarkers in a multicenter cohort of 1512 chronic HF patients: B-type natriuretic peptide (BNP), troponin 
I (TnI), high-sensitivity C-reactive protein (hsCRP), myeloperoxidase (MPO), soluble fms-like tyrosine kinase receptor-1 (sflt-1), soluble toll-like 
receptor-2 (ST2), creatinine (Cr), and uric acid (UA). Analysis was performed using a joint frailty model for recurrent events.
results: Over a maximum follow-up of 8.9 years, 843 participants experienced one or more cardiac hospitalizations (total 2178 hospitalizations). 
BNP and TnI exhibited the strongest associations with risk of hospitalization [HR 3.8 (95% CI 2.9-4.9) and HR 3.3 (95% CI 2.8-3.9); third vs. first 
tertile]. sFlt-1 exhibited the next strongest association [HR 2.8 (95% CI 2.4-3.4), followed by ST2 [HR 2.3 (95% CI 2.0-2.8)] and Cr [HR 1.9 (1.6-
2.4)]. hsCRP, MPO, and UA exhibited weaker but statistically significant associations. Within subgroups defined by ischemic or non-ischemic etiology, 
BNP and TnI remained most strongly associated, whereas the strength of the association for the remaining biomarkers varied by etiology.
conclusion: While BNP and TnI exhibited the strongest associations with risk of hospitalization, etiology-dependent associations for the remaining 
biomarkers suggest etiology-specific mechanisms for HF exacerbation. sFlt-1, a novel biomarker, exhibited a strong association with cardiac 
hospitalization, highlighting its potential role as a biomarker of HF morbidity.
